Press Releases

MYOS CEO Joseph Mannello Issues Letter to Shareholders Following Presentation at North American Veterinary Community (NAVC) Conference/VMX
MYOS RENS Technology Announces Study Results Demonstrating Fortetropin®, the Active Ingredient in Myos Canine Muscle Formula, Prevents Muscle Loss in Canines After Surgery and Enhances Recovery
MYOS RENS Technology Announces Upcoming Presentation of Results from a Kansas State University Study Evaluating the Impact of Fortetropin® on Canine Muscle Loss after Surgery, at a Major Veterinary Conference, January 20, 2019
MYOS RENS Technology Receives a New Patent from the United States Patent and Trademark Office
MYOS RENS Technology CEO Joseph Mannello Issues Letter to Shareholders
MYOS RENS Technology Announces Results of Its 2018 Annual Meeting of Stockholders
MYOS RENS Technology Launches 'Yolked®', Its Sports Nutrition Product, With The Vitamin Shoppe® Nationwide
MYOS RENS Technology Announces Approval of $1.2 Million in NJEDA NOL Program Tax Credits
MYOS RENS Technology Reports Financial Results for the Third Quarter of 2018 and Business Updates
MYOS RENS Technology Signs Distribution Agreement With Miller Veterinary Supply East To Bring Innovative MYOS Canine Muscle Formula™ To 6,000+ Veterinary Hospitals
RSS
Show All